Cls Holdings Plc · LSE:CLI
Cls — CLS Holdings USA — Investor Presentation (May 2021)
24 slides from Cls's investor presentation, May 11, 2021
Slide 1: Investor Presentation May 2021
eo — ( \ HOLDINGS USA, INC. X4 Li WV Investor Presentation May 2021
Slide 2: Forward Information and Risk Acknowledgement
Forward Information and Risk Acknowledgement This document contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995 (collectively, t
Slide 3: People Power Profits
ck joldingsinc.com “PEOPLE POWER PROFITS ndrew Glashow, President/COO ‘motto, People Power Profits, applies toall aspects of our business. Our dedicated ‘and the communities they belong toare adenvironmentsinthe ma tion providing aid to those mo tive partnershipwith the Arbor Day his people-firs in
Slide 4: Company Milestones
Company Milestones Completed ; purchase of <1 Rapid growth of City Trees BC Oasis Cannabis Productionand “7 Dispensary Innovation Facility in North Las Vegas Successfully completed multiple capital Completed purchase of Oasis Cannabis Dispensary in Las Vegas clsholdingsinc.com Completed build out of
Slide 5: Investment Overview
Investment Overview Oasis Cannabis dispensary in downtown Las Vegas supported by City Trees branded products and innovation Dispensary + Notadest Expanding national footprint creates licensing opportunities for core extraction technologies Production
Slide 6: Oasis Cannabis Dispensary
@ OASIS 2 aed CANNABI em sahiNorny
Slide 7: Oasis Dispensary Overview
Best Dispensary for Pot Pros. ———————— -Desert Companion Magazine, February 2019 ae 1 OASIS Was CANNABIS = DISPENSARY Dispensary Overview dele In-store, curbside, and trip and Downtown Las Vegas Highlights Prod
Slide 8: gasiscannabis.com
gasiscannabis.com
Slide 9: Giving Back
Giving Back Oasis Spirit of Giving From June 19, 2020 to September 20, 2020, we set aside 1% ofall net sales at Oasisto donate to organizations that benefit peoplemostaffected by the Waron Drugs. These funds will go toward providinglegal, medical, and additional communityresources to members of our
Slide 10: 0
0
Slide 11: Production and manufacturing facility
» O + < =| r) m m n 10,000 sa ft production and manufacturing facility based out of North Las Vegas, Nevada, capable of producingapproximately $1.7M each monthin revenue. We provide Nevada with high quality THC either effect-based or strain-specific flavors. late products infused with’ We use ethano
Slide 12: Tincture and distillate oil products
a BLUE AGAVE TINCTURE JACK HERER DISTILLATE OIL REFILLAPPLICATOR B inge
Slide 13: City Trees
GCITYTREES _ FIND YOUR att ue
Slide 14: Herbal Edibles licensing agreement
ALLA VAMOS ay 20: CLS Holdings finalized a licensing agreement with New Mexico-b: ed edible brand, Herbal Edibles Inc. to bring its a selling City od HERBAL EDIBLES GOURMET EDIBLES & COMPASSIONATE CONCENTRATES state. City T also gourmet, non-GMO, all organic e iain July 2024. This collat marks the C
Slide 15: Plant One
Plant One ov = Oo > P} re) citytrees.com
Slide 16: Board of Directors and Founding Members
S Board of Directors and Founding Mem Jeffrey Binder Ross Silver ‘Co-Founder, Chairman & CEO Board Member Andrew Glashow President & COO, Director
Slide 17: CLS Management Team
CLS Management Team q Jeffrey Binder Andrew Glashow Co-Founder, Chairman & CEO President & COO, Director Charlene Soco VP Finance CLS Nevada Isholdingsinc.com coRpre)
Slide 18: CLS Nevada Management and Key Employees
CLS Nevada Management and Key Employees Lissa Lawatsch Jamie Dickson General Manager, Oasis Cannabis Dispensary Executive Assistant currenth & Director of Human Resources, CLS Nevada James Gabany General Manager, City Trees # Me. Gabar ioldingsinc.cor
Slide 19: Financials
CL. Financials* ‘Annual Revenue EBITDA Nevada 2018" 42019 42020 £2021 $7,895,929 $11,974,571 $15,693,859 $22,000,000 -$1,043,105 $377,535 $909,809 $4,000,000 72000900 15693859 enigma 7995929 ‘s4c00000 sosss ‘eae = = aaggenes p2o9 p20 e021 ‘Arcus Revere EBITDA eeIr0A
Slide 20: CLS Nevada March Net Revenue and Gross Margin
CLS Nevada March Net Revenue and Gross Margin na019 12020 2024 ‘ Net Revenue in USD $1,068,607 $1054955 $2,024,208 i gs a | ete om 45% a0
Slide 21: Monthly Dispensary Transactions and Average Orders
CLS Nevada Monthly Dispensary Transactions and Average Orders pois pars A200 : i t i ‘Average Monthly 10.294 19,637 19,342 2 . t pee i oor sae saan ssa mreriemmamece
Slide 22: BDS Analytics Nevada Market Forecast
BDS Analytics Nevada Market Forecast* 1280 1000 2021 2022 2028 : Forecast Sales” $893M S18 $1,158 230 2 & g Forecast Sales fn mons) 221
Slide 23: Capitalization Table
Ca Ta b | e Expiry Date Exercise Price #Warrants p 30-Jul-24 $0.60 7,500,000 7-Aug-21 $0.60 6,875,000 12-Dec-24 $080 1,343,400" 7-Jan-22 $0.34 2,317,842 F-Jan-22 $0.49 2,317,842* T-Jan-22 $0.49 33,463,826 6-Feb-22 $050 1,740,000 21-Feb-22 $050 160,000 ‘Shares Outstanding 126,821,416 Seebo7 Soo; aa00
Slide 24: Contact
INT ON HOLDINGS USA, INC. X41 Lu WWJ @ 0515 Ses CANNABIS SS DIsPENSARY G CITYTREES Jeffrey Binder ‘Chairman/CEO Andrew Glashow President &COO T:888.438.9131 E:andrew@clsholdingsinc.com Visit:clsholdingsinc.com